T cell-NF-κB activation is required for tumor control in vivo

Journal for ImmunoTherapy of Cancer

Volumn 3, Issue 1, 2015, Pages

  Barnes, Sarah E ^a   Wang, Ying ^a   Chen, Luqiu ^a   Molinero, Luciana L ^b   Gajewski, Thomas F ^a   Evaristo, Cesar ^a   Alegre, Maria Luisa ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b GENENTECH INC   (United States)

Author keywords

Cytokine production; Cytotoxicity; Effector function; NF B; Priming; T cell; Tumor rejection

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNE RESPONSE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR REJECTION;

EID: 84977079216     PISSN: None     EISSN: 20511426     Source Type: Journal    
DOI: 10.1186/s40425-014-0045-x     Document Type: Article

References (61)

1. Coulie PG, Van Den Eynde BJ, Van Der Bruggen P, Boon T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 2014, 14(2):135-146. 10.1038/nrc3670, 24457417.
2. Chakraborty AK, Weiss A. Insights into the initiation of TCR signaling. Nat Immunol 2014, 15(9):798-807. 10.1038/ni.2940, 25137454.
3. Abe BT, Shin DS, Mocholi E, Macian F. NFAT1 supports tumor-induced anergy of CD4(+) T cells. Cancer Res 2012, 72(18):4642-4651. 10.1158/0008-5472.CAN-11-3775, 22865456.
4. Chow CW, Rincon M, Davis RJ. Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol 1999, 19(3):2300-2307. 10022916.
5. Xiao G, Deng A, Liu H, Ge G, Liu X. Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1. Proc Natl Acad Sci U S A 2012, 109(38):15419-15424. 10.1073/pnas.1206370109, 22949674.
6. Uzzo RG, Rayman P, Kolenko V, Clark PE, Cathcart MK, Bloom T, Novick AC, Bukowski RM, Hamilton T, Finke JH. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest 1999, 104(6):769-776. 10.1172/JCI6775, 10491412.
7. Broderick L, Brooks SP, Takita H, Baer AN, Bernstein JM, Bankert RB. IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin Immunol 2006, 118(2-3):159-169. 10.1016/j.clim.2005.09.008, 16271513.
8. Simpson-Abelson MR, Loyall JL, Lehman HK, Barnas JL, Minderman H, O'Loughlin KL, Wallace PK, George TC, Peng P, Kelleher RJ, Odunsi K, Bankert RB. Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-kappaB and NFAT signaling in tumor-associated T cells. Cancer Immun 2013, 13:14. 23882159.
9. Correa MR, Ochoa AC, Ghosh P, Mizoguchi H, Harvey L, Longo DL. Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J Immunol 1997, 158(11):5292-5296. 9164948.
10. Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL. Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res 1994, 54(11):2969-2972. 8187083.
11. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25(6):280-288. 10.1016/j.it.2004.03.008, 15145317.
12. Roche MI, Ramadas RA, Medoff BD. The role of CARMA1 in T cells. Crit Rev Immunol 2013, 33(3):219-243. 10.1615/CritRevImmunol.2013007056, 23756245.
13. Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med 1997, 185:1897-1907. 10.1084/jem.185.11.1897, 9166419.
14. Schmidt-Supprian M, Courtois G, Tian J, Coyle AJ, Israel A, Rajewsky K, Pasparakis M. Mature T cells depend on signaling through the IKK complex. Immunity 2003, 19(3):377-389. 10.1016/S1074-7613(03)00237-1, 14499113.
15. Jun JE, Wilson LE, Vinuesa CG, Lesage S, Blery M, Miosge LA, Cook MC, Kucharska EM, Hara H, Penninger JM, Domashenz H, Hong NA, Glynne RJK, Nelms KA, Goodnow CC. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 2003, 18(6):751-762. 10.1016/S1074-7613(03)00141-9, 12818157.
16. Egawa T, Albrecht B, Favier B, Sunshine MJ, Mirchandani K, O'Brien W, Thome M, Littman DR. Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol 2003, 13(14):1252-1258. 10.1016/S0960-9822(03)00491-3, 12867038.
17. Hara H, Wada T, Bakal C, Kozieradzki I, Suzuki S, Suzuki N, Nghiem M, Griffiths EK, Krawczyk C, Bauer B, D'Acquisto F, Ghosh S, Yeh WC, Baier G, Rottapel R, Penninger JM. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 2003, 18(6):763-775. 10.1016/S1074-7613(03)00148-1, 12818158.
18. Aronica MA, Mora AL, Mitchell DB, Finn PW, Johnson JE, Sheller JR, Boothby MR. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 1999, 163(9):5116-5124. 10528218.
19. Mora A, Youn J, Keegan A, Boothby M. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J Immunol 2001, 166(4):2218-2227. 10.4049/jimmunol.166.4.2218, 11160275.
20. Mora AL, Corn RA, Stanic AK, Goenka S, Aronica M, Stanley S, Ballard DW, Joyce S, Boothby M. Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ 2003, 10(9):1032-1044. 10.1038/sj.cdd.4401257, 12934078.
21. Molinero LL, Cubre A, Mora-Solano C, Wang Y, Alegre ML. T cell receptor/CARMA1/NF-kappaB signaling controls T-helper (Th) 17 differentiation. Proc Natl Acad Sci U S A 2012, 109(45):18529-18534. 10.1073/pnas.1204557109, 23091043.
22. Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, Van Kaer L, Boothby MR, Joyce S. NF-kappaB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J Immunol 2004, 172(4):2265-2273. 10.4049/jimmunol.172.4.2265, 14764695.
23. Molinero LL, Yang J, Gajewski T, Abraham C, Farrar MA, Alegre ML. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol 2009, 182(11):6736-6743. 10.4049/jimmunol.0900498, 19454668.
24. Barnes MJ, Krebs P, Harris N, Eidenschenk C, Gonzalez-Quintial R, Arnold CN, Crozat K, Sovath S, Moresco EM, Theofilopoulos AN, Beutler B, Hoebe K. Commitment to the Regulatory T Cell Lineage Requires CARMA1 in the Thymus but Not in the Periphery. PLoS Biol 2009, 7(3):e51. 10.1371/journal.pbio.1000051, 19260764.
25. Isomura I, Palmer S, Grumont RJ, Bunting K, Hoyne G, Wilkinson N, Banerjee A, Proietto A, Gugasyan R, Wu L, McNally A, Steptoe RJ, Thomas R, Shannon MF, Gerondakis S. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med 2009, 206(13):3001-3014. 10.1084/jem.20091411, 19995950.
26. Ruan Q, Kameswaran V, Tone Y, Li L, Liou HC, Greene MI, Tone M, Chen YH. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 2009, 31(6):932-940. 10.1016/j.immuni.2009.10.006, 20064450.
27. Visekruna A, Huber M, Hellhund A, Bothur E, Reinhard K, Bollig N, Schmidt N, Joeris T, Lohoff M, Steinhoff U. c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur J Immunol 2010, 40(3):671-676. 10.1002/eji.200940260, 20049877.
28. Molinero LL, Miller ML, Evaristo C, Alegre ML. High TCR stimuli prevent induced regulatory T cell differentiation in a NF-kappaB-dependent manner. J Immunol 2011, 186(8):4609-4617. 10.4049/jimmunol.1002361, 21411734.
29. Zhou P, Hwang KW, Palucki DA, Guo Z, Boothby M, Newell KA, Alegre ML. Impaired NF-kB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts. Amer J Transplant 2003, 3:139-147. 10.1034/j.1600-6143.2003.00033.x.
30. Porras DL, Wang Y, Zhou P, Molinero LL, Alegre ML. Role of T-cell-specific nuclear factor kappaB in islet allograft rejection. Transplantation 2012, 93(10):976-982. 10.1097/TP.0b013e31824d11d7, 22437847.
31. Schmidt-Supprian M, Tian J, Ji H, Terhorst C, Bhan AK, Grant EP, Pasparakis M, Casola S, Coyle AJ, Rajewsky K. I kappa B kinase 2 deficiency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion. J Immunol 2004, 173(3):1612-1619. 10.4049/jimmunol.173.3.1612, 15265889.
32. Silva A, Cornish G, Ley SC, Seddon B. NF-kappaB signaling mediates homeostatic maturation of new T cells. Proc Natl Acad Sci U S A 2014, 111(9):E846-E855. 10.1073/pnas.1319397111, 24550492.
33. Spiotto MT, Yu P, Rowley DA, Nishimura MI, Meredith SC, Gajewski TF, Fu YX, Schreiber H. Increasing tumor antigen expression overcomes " ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002, 17(6):737-747. 10.1016/S1074-7613(02)00480-6, 12479820.
34. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007, 13(11):460-469. 10.1016/j.molmed.2007.09.002, 18029230.
35. Prasad S, Ravindran J, Aggarwal BB. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 2010, 336(1-2):25-37. 10.1007/s11010-009-0267-2, 19823771.
36. Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L, Aifantis I. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007, 13(1):70-77. 10.1038/nm1524, 17173050.
37. Hopewell EL, Zhao W, Fulp WJ, Bronk CC, Lopez AS, Massengill M, Antonia S, Celis E, Haura EB, Enkemann SA, Chen DT, Beg AA. Lung tumor NF-kappaB signaling promotes T cell-mediated immune surveillance. J Clin Invest 2013, 123(6):2509-2522. 10.1172/JCI67250, 23635779.
38. Schmid JA, Birbach A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev 2008, 19(2):157-165. 10.1016/j.cytogfr.2008.01.006, 18308615.
39. Blonska M, Pappu BP, Matsumoto R, Li H, Su B, Wang D, Lin X. The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 2007, 26(1):55-66. 10.1016/j.immuni.2006.11.008, 17189706.
40. Gerondakis S, Fulford TS, Messina NL, Grumont RJ. NF-kappaB control of T cell development. Nat Immunol 2014, 15(1):15-25. 10.1038/ni.2785, 24352326.
41. Huang C, Bi E, Hu Y, Deng W, Tian Z, Dong C, Hu Y, Sun B. A novel NF-kappaB binding site controls human granzyme B gene transcription. J Immunol 2006, 176(7):4173-4181. 10.4049/jimmunol.176.7.4173, 16547254.
42. Sica A, Tan TH, Rice N, Kretzschmar M, Ghosh P, Young HA. The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci U S A 1992, 89(5):1740-1744. 10.1073/pnas.89.5.1740, 1542667.
43. Kline J, Zhang L, Battaglia L, Cohen KS, Gajewski TF. Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation. J Immunol 2012, 188(6):2630-2642. 10.4049/jimmunol.1100845, 22312128.
44. Mortenson ED, Park S, Jiang Z, Wang S, Fu YX. Effective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells. Clin Cancer Res 2013, 19(6):1476-1486. 10.1158/1078-0432.CCR-12-2522, 23363817.
45. Thiery J, Lieberman J. Perforin: a key pore-forming protein for immune control of viruses and cancer. Subcell Biochem 2014, 80:197-220. 10.1007/978-94-017-8881-6_10, 24798013.
46. Fields PE, Gajewski TF, Fitch FW. Blocked Ras activation in anergic CD4+ T cells. Science 1996, 271:1276-1278. 10.1126/science.271.5253.1276, 8638108.
47. Knudson KM, Hamilton SE, Daniels MA, Jameson SC, Teixeiro E. Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strength. J Immunol 2013, 191(12):5797-5801. 10.4049/jimmunol.1300905, 24244018.
48. Finn PW, Stone JR, Boothby MR, Perkins DL. Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol 2001, 167(10):5994-6001. 10.4049/jimmunol.167.10.5994, 11698479.
49. Molinero L, Zhou P, Wang Y, Harlin H, Cosmano J, Yokota Y, Kee B, Abraham C, Alegre ML. Epidermal Langerhans cells play a major role in skin allograft rejection in mice with NF-kB-impaired T cells. Am J Transplant 2008, 8:21-31. 18021281.
50. Molinero LL, Alegre ML. Role of T cell-nuclear factor kappaB in transplantation. Transplant Rev 2011, 26(3):189-200. 10.1016/j.trre.2011.07.005.
51. Alegre ML, Najafian N. Costimulatory molecules as targets for the induction of transplantation tolerance. Curr Mol Med 2006, 6(8):843-857. 10.2174/156652406779010812, 17168736.
52. Arch RH, Thompson CB. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol 1998, 18(1):558-565. 9418902.
53. Young Lee S, Yull Lee S, Kandala G, Liou M, Liou H, Choi Y. CD30/TNF receptor-associated factor interaction: NF-kB activation and binding specificity. Proc Natl Acad Sci USA 1996, 93(18):9699-9703. 10.1073/pnas.93.18.9699.
54. Martinez-Forero I, Azpilikueta A, Bolanos-Mateo E, Nistal-Villan E, Palazon A, Teijeira A, Perez-Chacon G, Morales-Kastresana A, Murillo O, Jure-Kunkel M, Zapata JM, Melero I. T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes. J Immunol 2013, 190(12):6694-6706. 10.4049/jimmunol.1203010, 23690480.
55. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21(2):137-148. 10.1016/j.immuni.2004.07.017, 15308095.
56. Harlin H, Hwang KW, Palucki DA, Kim O, Thompson CB, Boothby M, Alegre ML. CTLA-4 engagement regulates NF-kappaB activation in vivo. Eur J Immunol 2002, 32(8):2095-2104. 10.1002/1521-4141(200208)32:8<2095::AID-IMMU2095>3.0.CO;2-E, 12209621.
57. Qiao G, Li Z, Molinero L, Alegre ML, Ying H, Sun Z, Penninger JM, Zhang J. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol 2008, 28(7):2470-2480. 10.1128/MCB.01505-07, 18227156.
58. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Perez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JK, Tucker SM, Weaver WM, Kelso A, Jaenisch R, Wilson CB. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001, 15(5):763-774. 10.1016/S1074-7613(01)00227-8, 11728338.
59. Orban PC, Chui D, Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 1992, 89(15):6861-6865. 10.1073/pnas.89.15.6861, 1495975.
60. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, Krampert M, Goebeler M, Gillitzer R, Israel A, Krieg T, Rajewsky K, Haase I. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 2002, 417(6891):861-866. 10.1038/nature00820, 12075355.
61. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9(1):143-150. 10.1016/S1074-7613(00)80596-8, 9697844.